J&J's says its COVID-19 vaccine effectively combats Delta variant

Published July 2, 2021, 1:49 PM
Washington, United States — Johnson and Johnson’s single-shot COVID-19 vaccine is effective against the highly contagious Delta variant, with an immune response lasting at least eight months, the company said Thursday.
In this file photo taken on May 7, 2021 Johnson & Johnson COVID-19 vaccines are seen on a table at a vaccination clinic in Los Angeles. (Frederic J. BROWN / AFP / MANILA BULLETIN)
The antibodies and immune system cells in the blood of eight people vaccinated with the J&J jab effectively neutralized the Delta strain, which was first identified in India, researchers found.
A second study with 20 vaccinated patients at Boston’s Beth Israel Medical Center had similar results.

Related Keywords

United States ,India ,Washington ,Paul Stoffels ,Los Angeles ,Johnson ,Mathai Mammen ,Janssen Research Development At Johnson ,European Union ,Boston Beth Israel Medical Center ,Beth Israel Medical Center ,Janssen Research ,ஒன்றுபட்டது மாநிலங்களில் ,இந்தியா ,வாஷிங்டன் ,லாஸ் ஏஞ்சல்ஸ் ,ஜான்சன் ,மத்தாய் பாலூட்டிகள் ,ஜான்சன் ஆராய்ச்சி வளர்ச்சி இல் ஜான்சன் ,ஐரோப்பிய தொழிற்சங்கம் ,பெத் இஸ்ரேல் மருத்துவ மையம் ,ஜான்சன் ஆராய்ச்சி ,